Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "Please. Don't. Die.": A Grounded Theory Study of Bystander Cardiopulmonary Resuscitation.1 passage
• 'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial.1 passage
• 2015 Revised Utstein-Style Recommended Guidelines for Uniform Reporting of Data From Drowning-Related Resuscitation: An ILCOR Advisory Statement.1 passage
• 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.1 passage
• 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization).1 passage
• 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.1 passage
• 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).1 passage
• 2021 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19.1 passage
• A Blueprint for Productive Maintenance of Certification, But Is the American Board of Internal Medicine up to the Challenge?1 passage
• A Call to Reduce the Use of Bridging Anticoagulation.1 passage
• A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.1 passage
• A Network Approach to Stroke Systems of Care.1 passage
• ABCs of Stroke Prevention: Improving Stroke Outcomes in Children Supported With a Ventricular Assist Device in a Quality Improvement Network.1 passage
• ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons.1 passage
• Academic Outcomes in Children With Congenital Heart Defects: A Population-Based Cohort Study.1 passage
• Academic-Community Hospital Comparison of Vulnerabilities in Door-to-Needle Process for Acute Ischemic Stroke.1 passage
• Accuracy of Cardiovascular Trial Outcome Ascertainment and Treatment Effect Estimates from Routine Health Data: A Systematic Review and Meta-Analysis.1 passage
• Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.1 passage
• Acute Myocardial Infarction Cohorts Defined by1 passage
• Acute Myocardial Infarction Readmission Risk Prediction Models: A Systematic Review of Model Performance.1 passage
• Adapting and Evaluating a Health System Intervention From Kaiser Permanente to Improve Hypertension Management and Control in a Large Network of Safety-Net Clinics.1 passage
• Addition of Blood Pressure and Weight Transmissions to Standard Remote Monitoring of Implantable Defibrillators and its Association with Mortality and Rehospitalization.1 passage
• Addressing Gaps in Racial/Ethnic Representation in Familial Hypercholesterolemia Registries: Implications and Recommendations for Equitable Access to Research and Care.1 passage
• Addressing the Social Needs of Hypertensive Patients: The Role of Patient-Provider Communication as a Predictor of Medication Adherence.1 passage
• Adherence to Pediatric Universal Cholesterol Testing Guidelines Across Body Mass Index Categories: A CER1 passage
• Administrative Claims Measure for Profiling Hospital Performance Based on 90-Day All-Cause Mortality Following Coronary Artery Bypass Graft Surgery.1 passage
• Adult Congenital Heart Disease Patients Experience Similar Symptoms of Disease Activity.1 passage
• Advancing Value-Based Models for Heart Failure: A Call to Action From the Value in Healthcare Initiative's Value-Based Models Learning Collaborative.1 passage
• Adverse Change in Employment Status After Acute Myocardial Infarction: Analysis From the TRANSLATE-ACS Study.1 passage
• Adverse Pregnancy Conditions Among Privately Insured Women With and Without Congenital Heart Defects.1 passage
• African American Stroke Survivors: More Caregiving Time, but Less Caregiving Burden.1 passage
• Age-specific performance of the revised cardiac risk index for predicting cardiovascular risk in elective noncardiac surgery.1 passage
• Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial.1 passage
• American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines.1 passage
• An Observational Study of the Association of Video- Versus Text-Based Informed Consent With Multicenter Trial Enrollment: Lessons From the PALM Study (Patient and Provider Assessment of Lipid Management).1 passage
• Analysis of American College of Cardiology/American Heart Association Guideline Author Self-Disclosure Compared With Open Payments Industry Disclosure.1 passage
• Analysis of Machine Learning Techniques for Heart Failure Readmissions.1 passage
• Annual Incidence of Adult and Pediatric In-Hospital Cardiac Arrest in the United States1 passage
• Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration.1 passage
• Appropriateness of Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.1 passage
• Assessing Hospital Performance After Percutaneous Coronary Intervention Using Big Data.1 passage
• Assessing the Quality of Abstracts in Randomized Controlled Trials Published in High Impact Cardiovascular Journals.1 passage
• Assessment of Quality Indicators for Acute Myocardial Infarction in the FAST-MI (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) Registries.1 passage
• Association Between 30-Day Episode Payments and Acute Myocardial Infarction Outcomes Among Medicare Beneficiaries.1 passage
• Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).1 passage
• Association Between Early Outpatient Visits and Readmissions After Ischemic Stroke.1 passage
• Association Between Early Trauma and Ideal Cardiovascular Health Among Black Americans: Results From the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity.1 passage
• Association Between Hospital Debriefing Practices With Adherence to Resuscitation Process Measures and Outcomes for In-Hospital Cardiac Arrest.1 passage
• Association Between Hospital Recognition for Resuscitation Guideline Adherence and Rates of Survival for In-Hospital Cardiac Arrest.1 passage
• Association Between Hospital Teaching Status and Outcomes After Out-of-Hospital Cardiac Arrest.1 passage
• Association Between Increased Hospital Reimbursement for Cardiac Rehabilitation and Utilization of Cardiac Rehabilitation by Medicare Beneficiaries: An Interrupted Time Series.1 passage
• Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States.1 passage
• Association Between Living in Food Deserts and Cardiovascular Risk.1 passage
• Association Between Neighborhood Social Risk and Hospital Readmission Reduction Penalties Under the New Stratified Approach: Is Dual Eligibility Adjustment Enough?1 passage
• Association Between Physician Teamwork and Health System Outcomes After Coronary Artery Bypass Grafting.1 passage
• Association Between Postoperative Pneumonia and 90-Day Episode Payments and Outcomes Among Medicare Beneficiaries Undergoing Cardiac Surgery.1 passage
• Association Between Secondary Prevention Medication Use and Outcomes in Frail Older Adults After Acute Myocardial Infarction.1 passage
• Association Between a Healthy Heart Score and the Development of Clinical Cardiovascular Risk Factors Among Women: Potential Role for Primordial Prevention.1 passage
• Association between divorce and risks for acute myocardial infarction.1 passage
• Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease.1 passage
• Association of Cardiac Care Regionalization With Access, Treatment, and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction.1 passage
• Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease: The EUCLID Trial.1 passage
• Association of Implementation of Practice Standards for Electrocardiographic Monitoring With Nurses' Knowledge, Quality of Care, and Patient Outcomes: Findings From the Practical Use of the Latest Standards of Electrocardiography (PULSE) Trial.1 passage
• Association of Long-Term Exposure to Particulate Matter and Ozone With Health Status and Mortality in Patients After Myocardial Infarction.1 passage
• Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018.1 passage
• Association of Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.1 passage
• Association of Outpatient Practice-Level Socioeconomic Disadvantage With Quality of Care and Outcomes Among Older Adults With Coronary Artery Disease: Implications for Value-Based Payment.1 passage
• Association of Patient Enrollment in Medicare Part D With Outcomes After Acute Myocardial Infarction.1 passage
• Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates.1 passage
• Association of Race and Ethnicity and Anticoagulation in Patients with Atrial Fibrillation Dually Enrolled in VA and Medicare: Effects of Medicare Part D on Prescribing Disparities.1 passage
• Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial Infarction.1 passage
• Association of Surgeon Age and Experience With Congenital Heart Surgery Outcomes.1 passage
• Association of an Acute Myocardial Infarction Readmission-Reduction Program With Mortality and Readmission.1 passage
• Association of the Affordable Care Act's Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure.1 passage
• Associations of Medicaid Expansion With Access to Care, Severity, and Outcomes for Acute Ischemic Stroke.1 passage
• Atrial Fibrillation Burden Signature and Near-Term Prediction of Stroke: A Machine Learning Analysis.1 passage
• Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke.1 passage
• Automated and Interpretable Patient ECG Profiles for Disease Detection, Tracking, and Discovery.1 passage
• Availability, Sales, and Affordability of Tobacco Cessation Medicines in Kerala, India.1 passage
• Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of a Multicenter Registry.1 passage
• Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial.1 passage
• Bayesian Analysis: A Practical Approach to Interpret Clinical Trials and Create Clinical Practice Guidelines.1 passage
• Benefits and Harms of Hypertension and High-Normal Labels: A Randomized Experiment.1 passage
• Best Practices for Education and Training of Resuscitation Teams for In-Hospital Cardiac Arrest.1 passage
• Bioprosthetic Aortic Valve Replacement in Nonelderly Adults: A Systematic Review, Meta-Analysis, Microsimulation1 passage
• Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.1 passage
• Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus.1 passage
• Burden and Consequences of Financial Hardship From Medical Bills Among Nonelderly Adults With Diabetes Mellitus in the United States.1 passage
• COMPASS-CP: An Electronic Application to Capture Patient-Reported Outcomes to Develop Actionable Stroke and Transient Ischemic Attack Care Plans.1 passage
• Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework?1 passage
• Can physicians identify inappropriate nuclear stress tests? An examination of inter-rater reliability for the 2009 appropriate use criteria for radionuclide imaging.1 passage
• Cancellation of the Cardiac Catheterization Lab After Activation for ST-Segment-Elevation Myocardial Infarction.1 passage
• Cardiac Rehabilitation Dose Around the World: Variation and Correlates.1 passage
• Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention.1 passage
• Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.1 passage
• Cardiologist Participation in Accountable Care Organizations and Changes in Spending and Quality for Medicare Patients With Cardiovascular Disease.1 passage
• Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes.1 passage
• Cardiovascular Disease Events and Mortality After Myocardial Infarction Among Black and White Adults: REGARDS Study.1 passage
• Cardiovascular Disease Risk Factors and Myocardial Infarction in the Transgender Population.1 passage
• Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network.1 passage
• Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Cost-Effectiveness Analysis.1 passage
• Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF-TIMI 48 Trial.1 passage
• Care Trajectories of Veterans in the 12 Months After Hospitalization for Acute Ischemic Stroke.1 passage
• Care Transitions After Acute Myocardial Infarction for Transferred-In Versus Direct-Arrival Patients.1 passage
• Caregivers of Patients With Left Ventricular Assist Devices: Possible Impacts on Patients' Mortality and Interagency Registry for Mechanically Assisted Circulatory Support-Defined Morbidity Events.1 passage
• Catheterization Laboratory Activation Time in Patients Transferred With ST-Segment-Elevation Myocardial Infarction: Insights From the Mission: Lifeline STEMI Accelerator-2 Project.1 passage
• Cause of Death Among Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.1 passage
• Causes and Consequences of Missing Health-Related Quality of Life Assessments in Patients Who Undergo Mechanical Circulatory Support Implantation: Insights From INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).1 passage
• Causes of Mortality After Percutaneous Coronary Intervention.1 passage
• Change in Cognitive Function in the Month After Hospitalization for Acute Coronary Syndromes: Findings From TRACE-CORE (Transition, Risks, and Actions in Coronary Events-Center for Outcomes Research and Education).1 passage
• Changes in European Label and Guideline Adherence After Updated Recommendations for Stroke Thrombolysis: Results From the Safe Implementation of Treatments in Stroke Registry.1 passage
• Changes in Home Blood Pressure Monitored Among Elderly Patients With Hypertension During the COVID-19 Outbreak: A Longitudinal Study in China Leveraging a Smartphone-Based Application.1 passage
• Changes in Primary Noncardiac Diagnoses Over Time Among Elderly Cardiac Intensive Care Unit Patients in the United States.1 passage
• Characteristics and Outcomes of In-Hospital Cardiac Arrest Events During the COVID-19 Pandemic: A Single-Center Experience From a New York City Public Hospital.1 passage
• Characteristics and Outcomes of Stroke Patients Transferred to Hospitals Participating in the Michigan Coverdell Acute Stroke Registry.1 passage
• Characteristics and Quality of National Cardiac Registries: A Systematic Review.1 passage
• Characteristics and outcomes of women veterans undergoing cardiac catheterization in the Veterans Affairs Healthcare System: insights from the VA CART Program.1 passage
• Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure.1 passage
• Characterizing Teamwork in Cardiovascular Care Outcomes: A Network Analytics Approach.1 passage
• Chronic Stroke Outcome Measures for Motor Function Intervention Trials: Expert Panel Recommendations.1 passage
• Citizenship Status and the Prevalence, Treatment, and Control of Cardiovascular Disease Risk Factors Among Adults in the United States, 2011-2016.1 passage
• Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals.1 passage
• Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.1 passage
• Clinical Impact of Subsequent Depression in Patients With a New Diagnosis of Stable Angina: A Population-Based Study.1 passage
• Clinical Interventions to Reduce Preventable Hospital Readmission After Percutaneous Coronary Intervention.1 passage
• Clinical Model to Predict 90-Day Risk of Readmission After Acute Myocardial Infarction.1 passage
• Clinical Outcomes of Plavix and Generic Clopidogrel for Patients Hospitalized With an Acute Coronary Syndrome.1 passage
• Clinical Prediction Models for Cardiovascular Disease: Tufts Predictive Analytics and Comparative Effectiveness Clinical Prediction Model Database.1 passage
• Clinical Utility of Patient-Reported Outcome Measurement Information System Domain Scales.1 passage
• Clinical Value of Predicting Individual Treatment Effects for Intensive Blood Pressure Therapy.1 passage
• Clinical and Angiographic Predictors of Patient-Reported Angina 1 Year After Coronary Artery Bypass Graft Surgery.1 passage
• Cluster Randomized Clinical Trial of FAITH (Faith-Based Approaches in the Treatment of Hypertension) in Blacks.1 passage
• Cluster Randomized Trial Examining the Impact of Automated Best Practice Alert on Rates of Implantable Defibrillator Therapy.1 passage
• Cluster-Randomized Trial of Personalized Site Performance Feedback in Get With The Guidelines-Heart Failure.1 passage
• Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices.1 passage
• Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control.1 passage
• Collaborative Quality Improvement Reduces Postoperative Pneumonia After Isolated Coronary Artery Bypass Grafting Surgery.1 passage
• Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT Study.1 passage
• Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial Fibrillation.1 passage
• Comparative Effectiveness of Carotid Artery Stenting Versus Carotid Endarterectomy Among Medicare Beneficiaries.1 passage
• Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicenter Registry.1 passage
• Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients.1 passage
• Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events.1 passage
• Comparative Performance of Prediction Models for Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention.1 passage
• Comparative Safety of Aspiration Thrombectomy Catheters Utilizing Prospective, Active Surveillance of the NCDR CathPCI Registry.1 passage
• Comparing Outcomes of Coronary Artery Bypass Grafting Among Large Teaching and Urban Hospitals in China and the United States.1 passage
• Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States.1 passage
• Comparison of Clinically Adjudicated Versus Flow-Based Adjudication of Revascularization Events in Randomized Controlled Trials.1 passage
• Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY.1 passage
• Comparison of the Abilities of Summary Measures of International Normalized Ratio Control to Predict Clinically Relevant Bleeding.1 passage
• Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.1 passage
• Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE.1 passage
• Conflicting Perspectives on the Value of Neprilysin Inhibition in Heart Failure Revealed During Development of a Decision Aid Focusing on Patient Costs for Sacubitril/Valsartan.1 passage
• Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.1 passage
• Confluence of Cultural Context and Technological Innovation to Reduce Cardiovascular Disparities in India.1 passage
• Contemporary Trends in Hospital Admissions and Outcomes in Patients With Critical Limb Ischemia: An Analysis From the National Inpatient Sample Database.1 passage
• Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS1 passage
• Content Analysis of Social Media Related to Left Ventricular Assist Devices.1 passage
• Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial.1 passage
• Corrie Health Digital Platform for Self-Management in Secondary Prevention After Acute Myocardial Infarction.1 passage
• Cost Effectiveness of Interhospital Transfer for Mechanical Thrombectomy of Acute Large Vessel Occlusion Stroke: Role of Predicted Recanalization Rates.1 passage
• Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network1 passage
• Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial.1 passage
• Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.1 passage
• Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis.1 passage
• Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes.1 passage
• Decade-Long Trends (2001-2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction.1 passage
• Decision-making for destination therapy left ventricular assist devices: implications for caregivers.1 passage
• Decisions, Decisions, Decisions…: A Novel Approach Helps Evaluate Potential Benefit of Fetal Aortic Valvuloplasty.1 passage
• Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score.1 passage
• Defining Exposure in Observational Studies Comparing Outcomes of Treatment Discontinuation.1 passage
• Delays in Referral and Enrolment Are Associated With Mitigated Benefits of Cardiac Rehabilitation After Coronary Artery Bypass Surgery.1 passage
• Depressive Symptoms and Risk of Cardiovascular Events in Blacks: Findings From the Jackson Heart Study.1 passage
• Derivation and Validation of Prognosis-Based Age Cutoffs to Define Elderly in Cardiac Surgery.1 passage
• Deriving a Passive Surveillance Stroke Severity Indicator From Routinely Collected Administrative Data: The PaSSV Indicator.1 passage
• Design and Rationale of the RIPCORD 2 Trial (Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?): A Randomized Controlled Trial to Compare Routine Pressure Wire Assessment With Conventional Angiography in the Management of Patients With Coronary Artery Disease.1 passage
• Design, Challenges, and Implications of Quality Improvement Projects Using the Electronic Medical Record: Case Study: A Protocol to Reduce the Burden of Postoperative Atrial Fibrillation.1 passage
• Detecting Anomalies Among Practice Sites Within Multicenter Trials.1 passage
• Determinants of Hospital Variation in Cardiac Rehabilitation Enrollment During Coronary Artery Disease Episodes of Care.1 passage
• Determinants of Value in Coronary Artery Bypass Grafting.1 passage
• Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design.1 passage
• Development and Preliminary Validation of a Medicare Claims-Based Model to Predict Left Ventricular Ejection Fraction Class in Patients With Heart Failure.1 passage
• Development and Psychometric Properties of a Scale to Measure Hospital Organizational Culture for Cardiovascular Care.1 passage
• Development and Validation of Electronic Quality Measures to Assess Care for Patients With Transient Ischemic Attack and Minor Ischemic Stroke.1 passage
• Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.1 passage
• Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire.1 passage
• Development of a Portable Tool to Identify Patients With Atrial Fibrillation Using Clinical Notes From the Electronic Medical Record.1 passage
• Development of the Elective Outpatient Percutaneous Coronary Intervention Episode-Based Cost Measure.1 passage
• Difference or disparity: will big data improve our understanding of sex and cardiovascular disease?1 passage
• Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.1 passage
• Different Impacts of Time From Collapse to First Cardiopulmonary Resuscitation on Outcomes After Witnessed Out-of-Hospital Cardiac Arrest in Adults.1 passage
• Digital Health Intervention in Acute Myocardial Infarction.1 passage
• Direct Assessment of Health Utilities Using the Standard Gamble Among Patients With Primary Intracerebral Hemorrhage.1 passage
• Direct Transport to a Percutaneous Cardiac Intervention Center and Outcomes in Patients With Out-of-Hospital Cardiac Arrest.1 passage
• Disability-Adjusted Life Years Following Adult Out-of-Hospital Cardiac Arrest in the United States.1 passage
• Disparities and Impact of Medicaid Expansion on Left Ventricular Assist Device Implantation and Outcomes.1 passage
• Disparities in Management of Cardiovascular Disease in Rural South Africa: Data From the HAALSI Study (Health and Aging in Africa: Longitudinal Studies of International Network for the Demographic Evaluation of Populations and Their Health Communities).1 passage
• Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure.1 passage
• Do Acute Myocardial Infarction and Heart Failure Readmissions Flagged as Potentially Preventable by the 3M Potentially Preventable Readmissions Software Have More Process-of-Care Problems?1 passage
• Do Women With Anxiety or Depression Have Higher Rates of Myocardial Ischemia During Exercise Testing Than Men?1 passage
• Do-Not-Resuscitate Status and Risk-Standardized Mortality and Readmission Rates Following Acute Myocardial Infarction.1 passage
• Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.1 passage
• Does the Use of a Decision Aid Improve Decision Making in Prosthetic Heart Valve Selection? A Multicenter Randomized Trial.1 passage
• Does the Volume of Ischemic Stroke Admissions Relate to Clinical Outcomes in the Ontario Stroke System?1 passage
• Dog Ownership and Survival After a Major Cardiovascular Event: A Register-Based Prospective Study.1 passage
• Dog Ownership and Survival: A Systematic Review and Meta-Analysis.1 passage
• Doubly Robust Estimation of Causal Effect: Upping the Odds of Getting the Right Answers.1 passage
• Dyspnea Among Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Intervention: Prevalence and Predictors of Improvement.1 passage
• Early Detection of Heart Failure Using Electronic Health Records: Practical Implications for Time Before Diagnosis, Data Diversity, Data Quantity, and Data Density.1 passage
• Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation.1 passage
• Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.1 passage
• Echocardiographic and Electrocardiographic Abnormalities Among Elderly Adults With Cardiovascular Disease in Rural South Africa.1 passage
• Ecological Associations Between Inclusionary Zoning Policies and Cardiovascular Disease Risk Prevalence: An Observational Study.1 passage
• Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction.1 passage
• Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes.1 passage
• Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease.1 passage
• Effect of Prepublication Results on Trends in Prescribing of Antihypertensive Medication: Impact of the ALTITUDE (Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Disease Endpoints) Trial on Aliskiren Prescribing.1 passage
• Effect of Text Messaging on Risk Factor Management in Patients With Coronary Heart Disease: The CHAT Randomized Clinical Trial1 passage
• Effect of Variable Selection Strategy on the Performance of Prognostic Models When Using Multiple Imputation.1 passage
• Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial.1 passage
• Effect of the Lookback Period's Length Used to Identify Incident Acute Myocardial Infarction on the Observed Trends on Incidence Rates and Survival: Cardiovascular Disease in Norway Project.1 passage
• Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.1 passage
• Effectiveness of Left Atrial Appendage Exclusion Procedures to Reduce the Risk of Stroke: A Systematic Review of the Evidence.1 passage
• Effectiveness of Quality Improvement Interventions at Reducing Inappropriate Cardiac Imaging: A Systematic Review and Meta-Analysis.1 passage
• Effectiveness of Stroke Early Supported Discharge: Analysis From a National Stroke Registry.1 passage
• Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial1 passage
• Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary Syndrome: The Gratitude Research in Acute Coronary Events Study.1 passage
• Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.1 passage
• Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs.1 passage
• Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.1 passage
• Efficacy of a Chronic Care-Based Intervention on Secondary Stroke Prevention Among Vulnerable Stroke Survivors: A Randomized Controlled Trial.1 passage
• Electronic Health Record Integration of Predictive Analytics to Select High-Risk Stable Patients With Non-ST-Segment-Elevation Myocardial Infarction for Intensive Care Unit Admission.1 passage
• Electronic Stroke CarePath: Integrated Approach to Stroke Care.1 passage
• Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.1 passage
• Eliminating Postoperative Infections on a Budget: Collaborative Quality Improvement for Congenital Heart Surgery in Low- and Middle-Income Countries.1 passage
• Emergency Cardiovascular Hospitalization Risk Attributable to Cold Temperatures in Hong Kong.1 passage
• Emergency Department Volume and Outcomes for Patients After Chest Pain Assessment.1 passage
• Endometriosis and Risk of Coronary Heart Disease.1 passage
• Endovascular-First Treatment Is Associated With Improved Amputation-Free Survival in Patients With Critical Limb Ischemia.1 passage
• Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health Record.1 passage
• Epidemiology of Shock in Contemporary Cardiac Intensive Care Units.1 passage
• Episode Payments for Transcatheter and Surgical Aortic Valve Replacement.1 passage
• Establishing Thresholds for Minimal Clinically Important Differences for the Peripheral Artery Disease Questionnaire.1 passage
• Estimating Long-Term Health Utility Scores and Expenditures for Cardiovascular Disease From the Medical Expenditure Panel Survey.1 passage
• Estimating the Effect of Reduced Attendance at Emergency Departments for Suspected Cardiac Conditions on Cardiac Mortality During the COVID-19 Pandemic.1 passage
• Ethnic Differences in Prevalence of Post-stroke Depression.1 passage
• Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.1 passage
• Evidence for Therapeutic Patient Education Interventions to Promote Cardiovascular Patient Self-Management: A Scientific Statement for Healthcare Professionals From the American Heart Association.1 passage
• Evidence-Based Performance Measures and Outcomes in Patients With Acute Ischemic Stroke.1 passage
• Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials.1 passage
• Evolution of Age and Female Representation in the Most-Cited Randomized Controlled Trials of Cardiology of the Last 20 Years.1 passage
• Examining Hospital Variation on Multiple Indicators of Stroke Quality of Care.1 passage
• Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System.1 passage
• Examining the Prevalence of Adverse Childhood Experiences and Associated Cardiovascular Disease Risk Factors Among Low-Income Uninsured Adults.1 passage
• Exploring the Healthcare Value of Percutaneous Coronary Intervention: Appropriateness, Outcomes, and Costs in Michigan Hospitals.1 passage
• External Validations of Cardiovascular Clinical Prediction Models: A Large-Scale Review of the Literature.1 passage
• Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.1 passage
• Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015.1 passage
• Fall Risk and Outcomes Among Patients Hospitalized With Cardiovascular Disease in the Community.1 passage
• Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey.1 passage
• Feasibility of a Team Approach to Complex Congenital Heart Defect Neurodevelopmental Follow-Up: Early Experience of a Combined Cardiology/Neonatal Intensive Care Unit Follow-Up Program.1 passage
• Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome: A Decision Analysis.1 passage
• Few Disparities in Baseline Laboratory Testing After the Diuretic or Digoxin Initiation by Medicare Fee-For-Service Beneficiaries.1 passage
• Field Synopsis of Sex in Clinical Prediction Models for Cardiovascular Disease.1 passage
• First Medical Contact-to-Device Time and Heart Failure Outcomes Among Patients Undergoing Primary Percutaneous Coronary Intervention.1 passage
• Fish Oil and Perioperative Bleeding.1 passage
• Focusing on the Future of Cardiovascular Outcomes Research: Highlights From the American Heart Association/American Stroke Association Quality of Care and Outcomes Research 2018 Scientific Sessions.1 passage
• Fragility Index in Cardiovascular Randomized Controlled Trials.1 passage
• Frailty Trajectories After Treatment for Coronary Artery Disease in Older Patients.1 passage
• Frontiers of Upstream Stroke Prevention and Reduced Stroke Inequity Through Predicting, Preventing, and Managing Hypertension and Atrial Fibrillation: A Call to Action From the Value in Healthcare Initiative's Predict & Prevent Learning Collaborative.1 passage
• Future of the PCI Readmission Metric.1 passage
• Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction).1 passage
• Gender Disparities Among Adult Recipients of Bystander Cardiopulmonary Resuscitation in the Public.1 passage
• Gender-Related Differential Effects of Obesity on Health-Related Quality of Life via Obesity-Related Comorbidities: A Mediation Analysis of a French Nationwide Survey.1 passage
• Geriatric Conditions in Patients Undergoing Defibrillator Implantation for Prevention of Sudden Cardiac Death: Prevalence and Impact on Mortality.1 passage
• Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence.1 passage
• Guideline-Appropriate Care and In-Hospital Outcomes in Patients With Heart Failure in Teaching and Nonteaching Hospitals: Findings From Get With The Guidelines-Heart Failure.1 passage
• Harnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart Association.1 passage
• Harnessing Teams and Technology to Improve Outcomes in Infants With Single Ventricle.1 passage
• Health Economic Analysis of Access Site Practice in England During Changes in Practice: Insights From the British Cardiovascular Interventional Society.1 passage
• Health Equity and Implementation Science in Heart, Lung, Blood, and Sleep-Related Research: Emerging Themes From the 2018 Saunders-Watkins Leadership Workshop.1 passage
• Health Insurance Trajectories and Long-Term Survival After Heart Transplantation.1 passage
• Health Status Outcomes in Patients With Acute Myocardial Infarction After Rehospitalization.1 passage
• Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.1 passage
• Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.1 passage
• Health and Economic Implications of National Treatment Coverage for Cardiovascular Disease in India: Cost-Effectiveness Analysis.1 passage
• Health-Related Quality of Life and Angina in Fractional Flow Reserve- Versus Angiography-Guided Coronary Artery Bypass Grafting: FARGO Trial (Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization).1 passage
• Health-Related Quality of Life at 30 Days Among Indian Patients With Acute Myocardial Infarction.1 passage
• Healthcare Utilization and Expenditures Associated With Appropriate and Inappropriate Implantable Defibrillator Shocks.1 passage
• Heat Maps of Hypertension, Diabetes Mellitus, and Smoking in the Continental United States.1 passage
• Henry Ford HEART Score Randomized Trial: Rapid Discharge of Patients Evaluated for Possible Myocardial Infarction.1 passage
• High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris.1 passage
• Higher Emergency Physician Chest Pain Hospitalization Rates Do Not Lead to Improved Patient Outcomes.1 passage
• Highlights From the American Heart Association Quality of Care and Outcomes Research 2019 Scientific Sessions.1 passage
• Hospital Variation in Functional Recovery After Stroke.1 passage
• Hospital Variation in the Utilization and Implementation of Targeted Temperature Management in Out-of-Hospital Cardiac Arrest.1 passage
• Hospital and Operator Variation in Cardiac Rehabilitation Referral and Participation After Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortium.1 passage
• Hospital variation in quality of discharge summaries for patients hospitalized with heart failure exacerbation.1 passage
• Hospital-Based Quality Improvement Interventions for Patients With Acute Coronary Syndrome: A Systematic Review.1 passage
• Hospital-Level Cardiovascular Management Practices in Kerala, India.1 passage
• How the American Heart Association helped change women's heart health.1 passage
• Ideal Cardiovascular Health and Risk of Frailty in Older Adults.1 passage
• Identification of hospital outliers in bleeding complications after percutaneous coronary intervention.1 passage
• Identifying Drug-Drug Interactions by Data Mining: A Pilot Study of Warfarin-Associated Drug Interactions.1 passage
• Identifying Important Gaps in Randomized Controlled Trials of Adult Cardiac Arrest Treatments: A Systematic Review of the Published Literature.1 passage
• Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.1 passage
• Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).1 passage
• Impact of Food and Drug Administration Regulatory Approach on the 0/2-Hour Algorithm for Rapid Triage of Suspected Myocardial Infarction.1 passage
• Impact of Global Budget Payments on Cardiovascular Care in Maryland: An Interrupted Time Series Analysis.1 passage
• Impact of High Deductible Health Plans on Cardiovascular Medication Adherence and Health Disparities.1 passage
• Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults.1 passage
• Impact of Medicare's Bundled Payments Initiative on Patient Selection, Payments, and Outcomes for Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.1 passage
• Impact of Missing Stroke Severity Data on the Accuracy of Hospital Ischemic Stroke Mortality Profiling.1 passage
• Impact of Participation in a Telestroke Network on Clinical Outcomes.1 passage
• Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes.1 passage
• Impact of Relative Conditional Survival Estimates on Patient Prognosis After Percutaneous Coronary Intervention.1 passage
• Impact of Socioeconomic Status on Clinical Outcomes in Patients With ST-Segment-Elevation Myocardial Infarction.1 passage
• Impact of Telemonitoring on Health Status.1 passage
• Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients.1 passage
• Impact of Workplace Physical Activity Interventions on Physical Activity and Cardiometabolic Health Among Working-Age Women: A Systematic Review and Meta-Analysis.1 passage
• Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries.1 passage
• Impact of a Metoprolol Extended Release Shortage on Post-Myocardial Infarction β-Blocker Utilization, Adherence, and Rehospitalization.1 passage
• Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series Analysis.1 passage
• Impaired Cognition and Brain Atrophy Decades After Hypertensive Pregnancy Disorders.1 passage
• Impaired Health Status, Psychological Distress, and Personality in Women and Men With Nonobstructive Coronary Artery Disease: Sex and Gender Differences: The TWIST (Tweesteden Mild Stenosis) Study.1 passage
• Implementation of a Fast Healthcare Interoperability Resources-Based Clinical Decision Support Tool for Calculating CHA1 passage
• Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study.1 passage
• Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation.1 passage
• Importance of Housing and Cardiovascular Health and Well-Being: A Scientific Statement From the American Heart Association.1 passage
• Improved Prediction by Dynamic Modeling: An Exploratory Study in the Adult Cardiac Surgery Database of the Netherlands Association for Cardio-Thoracic Surgery.1 passage
• Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department.1 passage
• Improving Anticoagulation Measurement Novel Warfarin Composite Measure.1 passage
• Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative.1 passage
• Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner.1 passage
• Improving Outcome Predictions for Patients Receiving Mechanical Circulatory Support by Optimizing Imputation of Missing Values.1 passage
• Improving Temporal Trends in Survival and Neurological Outcomes After Out-of-Hospital Cardiac Arrest.1 passage
• In-Hospital Management and Outcomes After ST-Segment-Elevation Myocardial Infarction in Medicaid Beneficiaries Compared With Privately Insured Individuals.1 passage
• Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.1 passage
• Incidence and Survival After In-Hospital Cardiopulmonary Resuscitation in Nonelderly Adults: US Experience, 2007 to 2012.1 passage
• Incidence and Time Course for Developing Heart Failure With High-Burden Right Ventricular Pacing.1 passage
• Incidence and predictors of cognitive decline in patients with left ventricular assist devices.1 passage
• Increased Cardiovascular Disease Risk in Veterans With Mental Illness.1 passage
• Increased Risk of Adverse Neurocognitive Outcomes With Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors.1 passage
• Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada.1 passage
• Incremental Value of Repeated Risk Factor Measurements for Cardiovascular Disease Prediction in Middle-Aged Korean Adults: Results From the NHIS-HEALS (National Health Insurance System-National Health Screening Cohort).1 passage
• Individual Psychosocial Resilience, Neighborhood Context, and Cardiovascular Health in Black Adults: A Multilevel Investigation From the Morehouse-Emory Cardiovascular Center for Health Equity Study.1 passage
• Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.1 passage
• Innovative Managed Care May Be Related to Improved Prognosis for Acute Myocardial Infarction Survivors.1 passage
• Insulin Resistance and Risk of Cardiovascular Disease in Postmenopausal Women: A Cohort Study From the Women's Health Initiative.1 passage
• Integrated Care in Atrial Fibrillation: A Road Map to the Future.1 passage
• Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases.1 passage
• Integrating Quality of Life and Survival Outcomes in Cardiovascular Clinical Trials.1 passage
• Inter-Rater Reliability and Downstream Financial Implications of Electrocardiography Screening in Young Athletes.1 passage
• Interim Guidance for Emergency Medical Services Management of Out-of-Hospital Cardiac Arrest During the COVID-19 Pandemic.1 passage
• Interpreting Hemoglobin A1C in Combination With Conventional Risk Factors for Prediction of Cardiovascular Risk.1 passage
• Intracranial Hemorrhage After Ischemic Stroke: Incidence, Time Trends, and Predictors in a Swedish Nationwide Cohort of 196 765 Patients.1 passage
• Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis.1 passage
• Intravenous Tissue Plasminogen Activator in Stroke Mimics.1 passage
• Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?1 passage
• Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.1 passage
• Is Risk-Standardized In-Hospital Stroke Mortality an Adequate Proxy for Risk-Standardized 30-Day Stroke Mortality Data? Findings From Get With The Guidelines-Stroke.1 passage
• Joint Modeling of Longitudinal Markers and Time-to-Event Outcomes: An Application and Tutorial in Patients After Surgical Repair of Transposition of the Great Arteries.1 passage
• Joint Shock/Death Risk Prediction Model for Patients Considering Implantable Cardioverter-Defibrillators.1 passage
• Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations.1 passage
• Letter by Akinboboye and McDonald Regarding Article, "A Blueprint for Productive Maintenance of Certification, but Is the American Board of Internal Medicine up to the Challenge?"1 passage
• Letter by Boden Regarding Article, "Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials".1 passage
• Letter by Guo et al Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation".1 passage
• Letter by Hochman and Maron Regarding Article, "'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial."1 passage
• Letter by Nielsen and Søgaard Regarding Article, "Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort".1 passage
• Letter by Norris-Grey et al Regarding Article, "Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study".1 passage
• Letter by Pilz et al Regarding Article, "Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China".1 passage
• Letter by Priya et al Regarding Article, "Over-Testing for Suspected Pulmonary Embolism in American Emergency Departments: The Continuing Epidemic".1 passage
• Letter by Salata et al Regarding Article, "Utilization of Advanced Cardiovascular Therapies in the United States and Canada: An Observational Study of New York and Ontario Administrative Data".1 passage
• Letter by Shah Regarding Article, "Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials".1 passage
• Letter by Tanaka and Node Regarding Article, "Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study".1 passage
• Letter by Viswanath and Ahmad Regarding Article, "National Trends of Sex Disparity in the American College of Cardiology/American Heart Association Guideline Writing Committee Authors Over 15 Years".1 passage
• Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome.1 passage
• Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.1 passage
• Long-Term Persistence of Newly Initiated Warfarin Therapy in Chinese Patients With Nonvalvular Atrial Fibrillation.1 passage
• Long-Term Survival Among Patients With Myocardial Infarction Before Age 50 Compared With the General Population: A Danish Nationwide Cohort Study.1 passage
• Long-term cost-effectiveness of providing full coverage for preventive medications after myocardial infarction.1 passage
• Long-term effect of fee-for-service-based reimbursement cuts on processes and outcomes of care for stroke: interrupted time-series study from Taiwan.1 passage
• Longitudinal Spending on Endovascular and Open Abdominal Aortic Aneurysm Repair.1 passage
• Low-Value Transthoracic Echocardiography, Healthcare Utilization, and Clinical Outcomes in Patients With Coronary Artery Disease.1 passage
• Manual Versus Semiautomatic Rhythm Analysis and Defibrillation for Out-of-Hospital Cardiac Arrest.1 passage
• Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.1 passage
• Medicare Accountable Care Organizations Are Not Associated With Reductions in the Use of Low-Value Coronary Revascularization.1 passage
• Medicare Mandates for Shared Decision Making in Cardiovascular Device Placement.1 passage
• Medication Discontinuation in the IMPROVE-IT Trial.1 passage
• Mendelian Randomization in Cardiovascular Research: Establishing Causality When There Are Unmeasured Confounders.1 passage
• Menopause Characteristics, Total Reproductive Years, and Risk of Cardiovascular Disease Among Chinese Women.1 passage
• Meta-Analysis of Randomized Controlled Trials Comparing the Long-Term Outcomes of Carotid Artery Stenting Versus Endarterectomy.1 passage
• Michigan Stroke Transitions Trial.1 passage
• Microrandomized Trial Design for Evaluating Just-in-Time Adaptive Interventions Through Mobile Health Technologies for Cardiovascular Disease.1 passage
• Migration and Cardiovascular Disease Risk Among Ghanaian Populations in Europe: The RODAM Study (Research on Obesity and Diabetes Among African Migrants).1 passage
• Million Hearts Cardiac Rehabilitation Think Tank: Accelerating New Care Models.1 passage
• Mobile Phone-Based Questionnaire for Assessing 3 Months Modified Rankin Score After Acute Stroke: A Pilot Study.1 passage
• Modest Associations Between Electronic Health Record Use and Acute Myocardial Infarction Quality of Care and Outcomes: Results From the National Cardiovascular Data Registry.1 passage
• Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial.1 passage
• Morbidity and Mortality Conference for Percutaneous Coronary Intervention.1 passage
• More- Versus Less-Intensive Lipid-Lowering Therapy.1 passage
• Mortality From Ischemic Heart Disease.1 passage
• Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines).1 passage
• Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study.1 passage
• Multitype Events and the Analysis of Heart Failure Readmissions: Illustration of a New Modeling Approach and Comparison With Familiar Composite End Points.1 passage
• Myocardial Injury in Patients With Sepsis and Its Association With Long-Term Outcome.1 passage
• National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity.1 passage
• National Survey of UK Consultant Surgeons' Opinions on Surgeon-Specific Mortality Data in Cardiothoracic Surgery.1 passage
• Neighborhood Deprivation Predicts Heart Failure Risk in a Low-Income Population of Blacks and Whites in the Southeastern United States.1 passage
• Neighborhood Differences in Post-Stroke Mortality.1 passage
• Neighborhood Socioeconomic Disadvantage and Care After Myocardial Infarction in the National Cardiovascular Data Registry.1 passage
• Neoplasm Reports in Food and Drug Administration Adverse Event Reporting System Following Angiotensin Receptor Blocker Recalls.1 passage
• Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.1 passage
• New Method for Assessing the Effect of Driving Distance to Hospital Care: Using OpenStreetMap Routing in Cardiovascular Research.1 passage
• Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).1 passage
• Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack.1 passage
• Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times: Application in the Framingham Heart Study Community-Based Cohort.1 passage
• Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014-2018.1 passage
• Older patients with cardiac devices: the need for better patient-doctor conversations.1 passage
• Opportunities and Challenges of Claims-Based Quality Assessment: The Case of Postdischarge β-Blocker Treatment in Patients With Heart Failure With Reduced Ejection Fraction.1 passage
• Optimal Levels of All Major Cardiovascular Risk Factors in Younger Age and Functional Disability in Older Age: The Chicago Heart Association Detection Project in Industry 32-Year Follow-Up Health Survey.1 passage
• Optimal Methods for Reducing Proxy-Introduced Bias on Patient-Reported Outcome Measurements for Group-Level Analyses.1 passage
• Optimizing Atherosclerotic Cardiovascular Disease Risk Estimation for Veterans With Diabetes Mellitus.1 passage
• Organizational Structure, Staffing, Resources, and Educational Initiatives in Cardiac Intensive Care Units in the United States: An American Heart Association Acute Cardiac Care Committee and American College of Cardiology Critical Care Cardiology Working Group Cross-Sectional Survey.1 passage
• Over-Testing for Suspected Pulmonary Embolism in American Emergency Departments: The Continuing Epidemic.1 passage
• PCI Choice Decision Aid for Stable Coronary Artery Disease: A Randomized Trial.1 passage
• PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories): Overview of Design and Rationale of an International Prospective Peripheral Arterial Disease Study.1 passage
• PREPARED Study: A Study of Shared Decision-Making for Coronary Artery Disease.1 passage
• Paramedic Exposure to Out-of-Hospital Cardiac Arrest Resuscitation Is Associated With Patient Survival.1 passage
• Parity and Components of the Metabolic Syndrome Among US Hispanic/Latina Women: Results From the Hispanic Community Health Study/Study of Latinos.1 passage
• Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.1 passage
• Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention.1 passage
• Patient Characteristics and Outcomes After Hemorrhagic Stroke in Pregnancy.1 passage
• Patient and Physician Perspectives on Public Reporting of Mortality Ratings for Percutaneous Coronary Intervention in New York State.1 passage
• Patient-Centered Decision Support in Acute Ischemic Stroke: Qualitative Study of Patients' and Providers' Perspectives.1 passage
• Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy.1 passage
• Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013.1 passage
• Patients' and providers' perspectives of a polypill strategy to improve cardiovascular prevention in Australian primary health care: a qualitative study set within a pragmatic randomized, controlled trial.1 passage
• Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States.1 passage
• Perceived Stress and Depressive Symptoms as Predictors of Decisional Conflict in Dyads Considering a Left Ventricular Assist Device.1 passage
• Perceived Versus Actual Risks of 30-Day Readmission in Patients With Cardiovascular Disease.1 passage
• Perfect storm: concurrent stress and depressive symptoms increase risk of myocardial infarction or death.1 passage
• Performance Metrics for the Comparative Analysis of Clinical Risk Prediction Models Employing Machine Learning.1 passage
• Performance of the Meta-Analysis Global Group in Chronic Heart Failure Score in Black Patients Compared With Whites.1 passage
• Periprocedural Stroke and Myocardial Infarction as Risks for Long-Term Mortality in CREST.1 passage
• Personalized, Electronic Health Record-Integrated Decision Aid for Stroke Prevention in Atrial Fibrillation: A Small Cluster Randomized Trial and Qualitative Analysis of Efficacy and Acceptability.1 passage
• Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).1 passage
• Physician Network Connections Associated With Faster De-Adoption of Dronedarone for Permanent Atrial Fibrillation.1 passage
• Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular Data Registry's Research to Practice Initiative.1 passage
• Physician-Specific Practice Patterns About Discharge Readiness and Heart Failure Utilization Outcomes.1 passage
• Plugging the leaking pipeline: why men have a stake in the recruitment and retention of women in cardiovascular medicine and research.1 passage
• Policies allowing family presence during resuscitation and patterns of care during in-hospital cardiac arrest.1 passage
• Population-Based Assessment of the Incidence of Aortic Dissection, Intramural Hematoma, and Penetrating Ulcer, and Its Associated Mortality From 1995 to 2015.1 passage
• Population-Based Study on Patterns of Cardiac Stress Testing After Percutaneous Coronary Intervention.1 passage
• Post-Traumatic Stress Disorder and Cardiovascular Diseases: A Cohort Study of Men and Women Involved in Cleaning the Debris of the World Trade Center Complex.1 passage
• Postoperative Infection in Developing World Congenital Heart Surgery Programs: Data From the International Quality Improvement Collaborative.1 passage
• Practical Application of Patient-Reported Health Status Measures for Transcatheter Valve Therapies: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.1 passage
• Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States.1 passage
• Predicted Atherosclerotic Cardiovascular Disease Risk and Masked Hypertension Among Blacks in the Jackson Heart Study.1 passage
• Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus.1 passage
• Predicting Future Cardiovascular Events in Patients With Peripheral Artery Disease Using Electronic Health Record Data.1 passage
• Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency.1 passage
• Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population.1 passage
• Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).1 passage
• Predictors of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitor Prescriptions for Secondary Prevention of Clinical Atherosclerotic Cardiovascular Disease.1 passage
• Predictors of Physician Under-Recognition of Angina in Outpatients With Stable Coronary Artery Disease.1 passage
• Predictors of Rehospitalization Among Adults With Congenital Heart Disease Are Lesion Specific.1 passage
• Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis.1 passage
• Pregnancy in Women With a Fontan Circulation: A Systematic Review of the Literature.1 passage
• Preparedness and Mutuality Affect Quality of Life for Patients With Mechanical Circulatory Support and Their Caregivers.1 passage
• Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.1 passage
• Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public Payers.1 passage
• Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction.1 passage
• Priorities for Cardiovascular Outcomes Research: A Report of the National Heart, Lung, and Blood Institute's Centers for Cardiovascular Outcomes Research Working Group.1 passage
• Privacy-Preserving Generative Deep Neural Networks Support Clinical Data Sharing.1 passage
• Profiling Hospital Performance Based on Mortality After Transcatheter Aortic Valve Replacement in Ontario, Canada.1 passage
• Prognostic Implications of Level-of-Care at Tertiary Heart Centers Compared With Other Hospitals After Resuscitation From Out-of-Hospital Cardiac Arrest.1 passage
• Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department.1 passage
• Progression of Preclinical Heart Failure: A Description of Stage A and B Heart Failure in a Community Population.1 passage
• Provider Care Team Segregation and Operative Mortality Following Coronary Artery Bypass Grafting.1 passage
• Psychological Distress and Risk of Myocardial Infarction and Stroke in the 45 and Up Study.1 passage
• Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary Look.1 passage
• Quality of Care and Ischemic Stroke Risk After Hospitalization for Transient Ischemic Attack: Findings From Get With The Guidelines-Stroke.1 passage
• Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy.1 passage
• Quantifying Selection Bias in National Institute of Health Stroke Scale Data Documented in an Acute Stroke Registry.1 passage
• Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Blood Pressure-Lowering Effect of Renal Denervation.1 passage
• Quantifying the Shift Toward Transcatheter Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis.1 passage
• Quantifying the utility of taking pills for cardiovascular prevention.1 passage
• Race and Ethnicity: A Part of the Equation for Personalized Clinical Decision Making?1 passage
• Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.1 passage
• Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease: Insights From the CLEVER Trial (Claudication: Exercise Versus Endoluminal Revascularization).1 passage
• Racial and Ethnic Differences in Antihypertensive Medication Use and Blood Pressure Control Among US Adults With Hypertension: The National Health and Nutrition Examination Survey, 2003 to 2012.1 passage
• Racial, Ethnic, and Socioeconomic Inequities in the Prescription of Direct Oral Anticoagulants in Patients With Venous Thromboembolism in the United States.1 passage
• Randomized Comparison of High-Sensitivity Troponin Reporting in Undifferentiated Chest Pain Assessment.1 passage
• Randomized Controlled Trial of E-Counseling for Hypertension: REACH.1 passage
• Randomized Pragmatic Trial of Stroke Transitional Care: The COMPASS Study.1 passage
• Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.1 passage
• Randomized Trial of an Intervention to Improve Blood Pressure Control in Stroke Survivors.1 passage
• Rapid Diet Assessment Screening Tools for Cardiovascular Disease Risk Reduction Across Healthcare Settings: A Scientific Statement From the American Heart Association.1 passage
• Rates and Predictors of Patient Underreporting of Hospitalizations During Follow-Up After Acute Myocardial Infarction: An Assessment From the TRIUMPH Study.1 passage
• Rates, Characteristics, and Outcomes of Patients Transferred to Specialized Stroke Centers for Advanced Care.1 passage
• Rationale and Design of EMPOWER, a Pragmatic Randomized Trial of Automated Hovering in Patients With Congestive Heart Failure.1 passage
• Rationale and Design of the SAFE-PAD Study.1 passage
• Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.1 passage
• Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries.1 passage
• Recognition of incident diabetes mellitus during an acute myocardial infarction.1 passage
• Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of Cardiology/Multisociety, US Preventive Services Task Force, Department of Veterans Affairs/Department of Defense, Canadian Cardiovascular Society, and European Society of Cardiology/European Atherosclerosis Society Clinical Practice Guidelines.1 passage
• Recommendations for Reporting Machine Learning Analyses in Clinical Research.1 passage
• Recurrent Neural Networks for Early Detection of Heart Failure From Longitudinal Electronic Health Record Data: Implications for Temporal Modeling With Respect to Time Before Diagnosis, Data Density, Data Quantity, and Data Type.1 passage
• Redefining Resistant Hypertension: A Comparison of Cardiovascular Risk Associated With the 2018 Versus 2008 American Heart Association Definitions for Resistant Hypertension.1 passage
• Referral to Cardiac Rehabilitation After Percutaneous Coronary Intervention, Coronary Artery Bypass Surgery, and Valve Surgery: Data From the Clinical Outcomes Assessment Program.1 passage
• Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times.1 passage
• Regional Variation in 30-Day Ischemic Stroke Outcomes for Medicare Beneficiaries Treated in Get With The Guidelines-Stroke Hospitals.1 passage
• Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants.1 passage
• Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points.1 passage
• Relationship Between Physician and Hospital Procedure Volume and Mortality After Carotid Artery Stenting Among Medicare Beneficiaries.1 passage
• Relationship of Preeclampsia With Maternal Place of Birth and Duration of Residence Among Non-Hispanic Black Women in the United States.1 passage
• Relationship of Provider and Practice Volume to Performance Measure Adherence for Coronary Artery Disease, Heart Failure, and Atrial Fibrillation: Results From the National Cardiovascular Data Registry.1 passage
• Reliability and Validity of Current Approaches to Identification of Patients with ST-Segment-Elevation Myocardial Infarction.1 passage
• Reporting and replicating trials of exercise-based cardiac rehabilitation: do we know what the researchers actually did?1 passage
• Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.1 passage
• Response by Ahmad et al to Letter Regarding Article "Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials".1 passage
• Response by Ahmad et al to Letter Regarding Article, "Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials".1 passage
• Response by Alyesh et al to Letter Regarding Article, "A Blueprint for Productive Maintenance of Certification, but Is the American Board of Internal Medicine up to the Challenge?"1 passage
• Response by Bonde and Martinussen to Letter Regarding Article, "Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort".1 passage
• Response by Cram et al to Letter Regarding Article, "Utilization of Advanced Cardiovascular Therapies in the United States and Canada: An Observational Study of New York and Ontario Administrative Data".1 passage
• Response by Hoque et al to Letter Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation".1 passage
• Response by Kline to Letter Regarding Article, "Over-Testing for Suspected Pulmonary Embolism in American Emergency Departments: The Continuing Epidemic".1 passage
• Response by Nallamothu to Letter Regarding Article, "Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials".1 passage
• Response by Pinheiro et al to Letter Regarding Article, "Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study".1 passage
• Response by Rai et al to Letter Regarding Article, "National Trends of Sex Disparity in the American College of Cardiology/American Heart Association Guideline Writing Committee Authors Over 15 Years".1 passage
• Response by Wasfy et al to Letter Regarding Article, "Association of an Acute Myocardial Infarction Readmission-Reduction Program With Mortality and Readmission".1 passage
• Return to Work After Acute Myocardial Infarction: Comparison Between Young Women and Men.1 passage
• Return to Work and Participation in Society After Out-of-Hospital Cardiac Arrest.1 passage
• Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).1 passage
• Rheumatic Heart Disease Treatment Cascade in Uganda.1 passage
• Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF Registry.1 passage
• Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease: An Analysis of Post RAISE.1 passage
• Risk Stratification of Patients Undergoing Percutaneous Repair of Mitral and Tricuspid Valves Using a Multidimensional Geriatric Assessment.1 passage
• Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent: How Important Is the Interplay Between Stent Type and Time From Stenting to Surgery?1 passage
• Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort.1 passage
• Role of Spirituality on the Association Between Depression and Quality of Life in Stroke Survivor-Care Partner Dyads.1 passage
• Rural-Urban Differences in Stroke Risk Factors, Incidence, and Mortality in People With and Without Prior Stroke.1 passage
• SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.1 passage
• Safer Stroke-Dx Instrument: Identifying Stroke Misdiagnosis in the Emergency Department.1 passage
• Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.1 passage
• Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.1 passage
• Screening for Intracranial Aneurysms in Coarctation of the Aorta: A Decision and Cost-Effectiveness Analysis.1 passage
• Self-blood pressure monitoring in an urban, ethnically diverse population: a randomized clinical trial utilizing the electronic health record.1 passage
• Semi-Competing Risks Data Analysis: Accounting for Death as a Competing Risk When the Outcome of Interest Is Nonterminal.1 passage
• Sequential Monitoring of the Comparative Effectiveness and Safety of Dabigatran in Routine Care.1 passage
• Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation.1 passage
• Sex Differences in Inflammatory Markers and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients) Study.1 passage
• Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps.1 passage
• Sex Differences in Long-Term Mortality After Stroke in the INSTRUCT (INternational STRoke oUtComes sTudy): A Meta-Analysis of Individual Participant Data.1 passage
• Sex Differences in Outcomes Following Percutaneous Coronary Intervention According to Age.1 passage
• Sex Differences in Symptom Phenotypes Among Patients With Acute Myocardial Infarction.1 passage
• Sex Differences in Trajectories of Risk After Rehospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia.1 passage
• Sex Differences in the Epidemiology of New-Onset In-Hospital Post-Coronary Artery Bypass Graft Surgery Atrial Fibrillation: A Large Multicenter Study.1 passage
• Sex Differences in the Incidence of Peripheral Artery Disease in the Chronic Renal Insufficiency Cohort.1 passage
• Sex Differences in the Use of Statins in Community Practice.1 passage
• Sex Disparities in Authorship Order of Cardiology Scientific Publications.1 passage
• Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women.1 passage
• Sex and Ethnic Differences in Outcomes of Acute Coronary Syndrome and Stable Angina Patients With Obstructive Coronary Artery Disease.1 passage
• Sex and Race/Ethnicity-Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults.1 passage
• Sex is associated with differences in individual trajectories of change in social health after implantable cardioverter-defibrillator.1 passage
• Sex, Drugs, and Adverse Drug Reactions: Sex Differences in Laboratory Monitoring Outcomes After Initiation of Renin-Angiotensin-Aldosterone-System Inhibition Therapy.1 passage
• Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute Myocardial Infarction: The SILVER-AMI Study.1 passage
• Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.1 passage
• Sex-Specific Determinants of Outcomes After Transcatheter Aortic Valve Replacement.1 passage
• Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years.1 passage
• Shared Decision-Making for Left Ventricular Assist Devices: Rationale and Design of a Nationwide Dissemination and Implementation Project.1 passage
• Short-Term Risk of Serious Fall Injuries in Older Adults Initiating and Intensifying Treatment With Antihypertensive Medication.1 passage
• Show Me the Money: Patients' Perspectives on a Decision Aid for Sacubitril/Valsartan Addressing Out-of-Pocket Cost.1 passage
• Simulation-Based Mastery Learning Improves Patient and Caregiver Ventricular Assist Device Self-Care Skills: A Randomized Pilot Trial.1 passage
• Site-Level Variability in 30-Day Patient Outcomes After Transcatheter Mitral Valve Repair in the United States.1 passage
• Smartphone-Based Geofencing to Ascertain Hospitalizations.1 passage
• Smoking Paradox in Patients Hospitalized With Coronary Artery Disease or Acute Ischemic Stroke: Findings From Get With The Guidelines.1 passage
• Social Determinants of Adherence to COVID-19 Risk Mitigation Measures Among Adults With Cardiovascular Disease.1 passage
• Social Determinants of Health Improve Predictive Accuracy of Clinical Risk Models for Cardiovascular Hospitalization, Annual Cost, and Death.1 passage
• Socioeconomic Burden of Rising Methamphetamine-Associated Heart Failure Hospitalizations in California From 2008 to 2018.1 passage
• Socioeconomic Deprivation and Survival After Heart Transplantation in England: An Analysis of the United Kingdom Transplant Registry.1 passage
• Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?1 passage
• Socioeconomic Status and Outcomes in Heart Failure With Reduced Ejection Fraction From Asia.1 passage
• Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012-2018.1 passage
• Sources of Hospital Variation in Postacute Care Spending After Cardiac Surgery.1 passage
• Spouse's Cardiovascular Disease As a Risk Factor for Cardiovascular Disease in Middle-Aged Adults: A Matched-Pair Cohort Study.1 passage
• Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction: A Cohort Study.1 passage
• Status of cardiovascular health in US children up to 11 years of age: the National Health and Nutrition Examination Surveys 2003-2010.1 passage
• Streamlining and Reimagining Prior Authorization Under Value-Based Contracts: A Call to Action From the Value in Healthcare Initiative's Prior Authorization Learning Collaborative.1 passage
• Stress Testing After Percutaneous Coronary Intervention in the Veterans Affairs HealthCare System: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.1 passage
• Stress, Resilience, and Cardiovascular Disease Risk Among Black Women.1 passage
• Suboptimal Management of Cardiovascular Risk Factors Among Non-US-Citizen Immigrants: Time to Build a Healthier Immigrant Workforce in the United States.1 passage
• Success, Failure, and Transparency in Biomarker-Based Drug Development: A Case Study of Cholesteryl Ester Transfer Protein Inhibitors.1 passage
• Sudden Cardiac Death in the Young: Incidence, Trends, and Risk Factors in a Nationwide Study.1 passage
• Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.1 passage
• Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration.1 passage
• Symptom recognition and healthcare experiences of young women with acute myocardial infarction.1 passage
• Syncope and Its Impact on Occupational Accidents and Employment: A Danish Nationwide Retrospective Cohort Study.1 passage
• Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility Index.1 passage
• Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients.1 passage
• Systemizing the Evaluation of Acute Heart Failure in the Emergency Department: A Quality Improvement Initiative.1 passage
• Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.1 passage
• Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries.1 passage
• Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy.1 passage
• Temporal Trends in Use of Composite End Points in Major Cardiovascular Randomized Clinical Trials in Prominent Medical Journals.1 passage
• Temporal Trends of Out-of-Hospital Cardiac Arrests Without Resuscitation Attempt by Emergency Medical Services.1 passage
• Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).1 passage
• Text Message Medication Adherence Reminders Automated and Delivered at Scale Across Two Institutions: Testing the Nudge System: Pilot Study.1 passage
• The Accreditation Council for Graduate Medical Education Mandates That You Attempt to Enhance Diversity in Your Cardiology Program: Great! (How Do We Do That?).1 passage
• The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services.1 passage
• The Cardiovascular Quality Improvement and Care Innovation Consortium: Inception of a Multicenter Collaborative to Improve Cardiovascular Care.1 passage
• The Effect of Medicare Accountable Care Organizations on Early and Late Payments for Cardiovascular Disease Episodes.1 passage
• The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge.1 passage
• The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study: A Pragmatic Randomized Trial.1 passage
• The PCORnet Blood Pressure Control Laboratory: A Platform for Surveillance and Efficient Trials.1 passage
• The Role of Frailty in Identifying Benefit from Transcatheter Versus Surgical Aortic Valve Replacement.1 passage
• The Ross Procedure: A Systematic Review, Meta-Analysis, and Microsimulation.1 passage
• The Two-Edged Sword of Shared Clinical Decision-Making in the Post-ISCHEMIA World of Stable Coronary Artery Disease Management: Clinical Commentary on "It Happened So Fast … I Guess, Yes, I Was Lucky".1 passage
• The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance.1 passage
• Thirty-Day Hospital Readmission After Acute Myocardial Infarction in China.1 passage
• Thirty-Day Readmission Risk Model for Older Adults Hospitalized With Acute Myocardial Infarction.1 passage
• Thirty-Year Mortality After Coronary Artery Bypass Graft Surgery: A Danish Nationwide Population-Based Cohort Study.1 passage
• Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care.1 passage
• Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality: A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency Cases.1 passage
• Toward Dynamic Risk Prediction of Outcomes After Coronary Artery Bypass Graft: Improving Risk Prediction With Intraoperative Events Using Gradient Boosting.1 passage
• Tracking Cardiac Rehabilitation Participation and Completion Among Medicare Beneficiaries to Inform the Efforts of a National Initiative.1 passage
• Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China.1 passage
• Trajectories of Health-Related Quality of Life in Coronary Artery Disease.1 passage
• Trajectories of Pain After Cardiac Surgery: Implications for Measurement, Reporting, and Individualized Treatment.1 passage
• Trajectory of Risk-Standardized Survival Rates for In-Hospital Cardiac Arrest.1 passage
• Transcatheter Aortic Valve Replacement in Low-Population Density Areas: Assessing Healthcare Access for Older Adults With Severe Aortic Stenosis.1 passage
• Treatment Deintensification Is Uncommon in Adults With Type 2 Diabetes Mellitus: A Retrospective Cohort Study.1 passage
• Treatments and Mortality Trends in Cases With and Without Dialysis Who Have an Acute Myocardial Infarction: An 18-Year Nationwide Experience.1 passage
• Tree-Based Analysis.1 passage
• Trends and Outcomes After Same-Day Discharge After Percutaneous Coronary Interventions.1 passage
• Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria.1 passage
• Trends in Outcomes of Patients With Ischemic Stroke Treated Between 2002 and 2016: Insights From a Chinese Cohort.1 passage
• Trends in Performance and Opportunities for Improvement on a Composite Measure of Acute Myocardial Infarction Care.1 passage
• Trends in Telestroke Care Delivery: A 15-Year Experience of an Academic Hub and Its Network of Spokes.1 passage
• Trends in hypertension control among the older population of Spain from 2000 to 2001 to 2008 to 2010: role of frequency and intensity of drug treatment.1 passage
• Trends of Coronary Artery Bypass Grafting Performance in a Cohort of Hospitals in China Between 2013 and 2018.1 passage
• True Negatives: Disseminating Research on Null, Inconclusive, and Confirmatory Findings in Cardiovascular Science.1 passage
• Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study.1 passage
• Understanding How Patients Fare: Insights Into the Health Status Patterns of Patients With Coronary Disease and the Future of Evidence-Based Shared Medical Decision-Making.1 passage
• Urban-Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment-Elevation Myocardial Infarction in China From 2001 to 2011: A Retrospective Analysis From the China PEACE Study (Patient-Centered Evaluative Assessment of Cardiac Events).1 passage
• Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer: A Nationwide Nested Case-Control Study.1 passage
• Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.1 passage
• Use of Mixed Methods Research in Research on Coronary Artery Disease, Diabetes Mellitus, and Hypertension: A Scoping Review.1 passage
• Use of Mobile Health Applications in Low-Income Populations: A Prospective Study of Facilitators and Barriers.1 passage
• Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.1 passage
• Using a cardiac arrest registry to measure the quality of emergency medical service care: decade of findings from the Victorian Ambulance Cardiac Arrest Registry.1 passage
• Utilization and Availability of Advanced Imaging in Patients With Acute Ischemic Stroke.1 passage
• Utilization of Advanced Cardiovascular Therapies in the United States and Canada: An Observational Study of New York and Ontario Administrative Data.1 passage
• Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy.1 passage
• Utilization of Generic Cardiovascular Drugs in Medicare's Part D Program.1 passage
• Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines.1 passage
• Validating Publicly Available Crosswalks for Translating ICD-9 to ICD-10 Diagnosis Codes for Cardiovascular Outcomes Research.1 passage
• Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical Trial.1 passage
• Validation of an Organizational Management Model of Remote Implantable Cardioverter-Defibrillator Monitoring Alerts.1 passage
• Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation.1 passage
• Value in Healthcare Initiative: Summary and Key Recommendations.1 passage
• Value-Based ST-Segment-Elevation Myocardial Infarction Care Using Risk-Guided Triage and Early Discharge.1 passage
• Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay.1 passage
• Variation and Trends in the Documentation of National Institutes of Health Stroke Scale in GWTG-Stroke Hospitals.1 passage
• Variation in Hospital Risk-Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.1 passage
• Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.1 passage
• Video-Only Cardiopulmonary Resuscitation Education for High-Risk Families Before Hospital Discharge: A Multicenter Pragmatic Trial.1 passage
• What Is in a Name? How Biomedical Language May Derail Patient Understanding of Hypertension.1 passage
• When Blue-Collars Feel Blue: Depression and Low Occupational Grade as Synergistic Predictors of Incident Cardiac Events in Middle-Aged Working Individuals.1 passage
• Who Must We Target Now to Minimize Future Cardiovascular Events and Total Mortality?: Lessons From the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) Cohort Study.1 passage
• Working Agenda for Black Mothers: A Position Paper From the Association of Black Cardiologists on Solutions to Improving Black Maternal Health.1 passage
• Young Women With Acute Myocardial Infarction: Current Perspectives.1 passage